BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32236306)

  • 1. EIF1AX c.338-2A>T splice site mutation in a patient with trabecular adenoma and cytological indeterminate lesion.
    Castagna MG; Pilli T; Maino F; Marzocchi C; Cairano GD; Cantara S
    Arch Endocrinol Metab; 2020 Apr; 64(2):185-189. PubMed ID: 32236306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and phenotypic correlations of EIF1AX mutations in thyroid nodules.
    Karunamurthy A; Panebianco F; J Hsiao S; Vorhauer J; Nikiforova MN; Chiosea S; Nikiforov YE
    Endocr Relat Cancer; 2016 Apr; 23(4):295-301. PubMed ID: 26911375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TERT, HRAS, and EIF1AX Mutations in a Patient with Follicular Adenoma.
    Topf MC; Wang ZX; Tuluc M; Pribitkin EA
    Thyroid; 2018 Jun; 28(6):815-817. PubMed ID: 29669480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EIF1AX Mutation in a Patient with Hürthle Cell Carcinoma.
    Topf MC; Wang ZX; Furlong K; Miller JL; Tuluc M; Pribitkin EA
    Endocr Pathol; 2018 Mar; 29(1):27-29. PubMed ID: 28965201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EIF1AX mutation in thyroid tumors: a retrospective analysis of cytology, histopathology and co-mutation profiles.
    Elsherbini N; Kim DH; Payne RJ; Hudson T; Forest VI; Hier MP; Payne AE; Pusztaszeri MP
    J Otolaryngol Head Neck Surg; 2022 Nov; 51(1):43. PubMed ID: 36371345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and Clinical Significance of EIF1AX Mutations and Co-Mutations in Cytologically Indeterminate Thyroid Nodules: A 5-Year Retrospective Analysis.
    Gargano SM; Badjatia N; Nikolaus Y; Peiper SC; Wang ZX
    Acta Med Acad; 2021 Apr; 50(1):4-12. PubMed ID: 34075760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer.
    Alzahrani AS; Murugan AK; Qasem E; Alswailem MM; AlGhamdi B; Moria Y; Al-Hindi H
    Endocrine; 2019 Jan; 63(1):94-100. PubMed ID: 30269267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of EIF1AX in thyroid cancer tumourigenesis and progression.
    Simões-Pereira J; Moura MM; Marques IJ; Rito M; Cabrera RA; Leite V; Cavaco BM
    J Endocrinol Invest; 2019 Mar; 42(3):313-318. PubMed ID: 29968046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors.
    Jung CK; Kim Y; Jeon S; Jo K; Lee S; Bae JS
    Hum Pathol; 2018 Nov; 81():9-17. PubMed ID: 29723601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features and outcomes of thyroid nodules with EIF1AX mutations.
    Karslioglu French E; Nikitski AV; Yip L; Nikiforova MN; Nikiforov YE; Carty SE
    Endocr Relat Cancer; 2022 Aug; 29(8):467-473. PubMed ID: 35609001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology.
    Cantara S; Capezzone M; Marchisotta S; Capuano S; Busonero G; Toti P; Di Santo A; Caruso G; Carli AF; Brilli L; Montanaro A; Pacini F
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1365-9. PubMed ID: 20130073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.
    Bongiovanni M; Molinari F; Eszlinger M; Paschke R; Barizzi J; Merlo E; Giovanella L; Fasolini F; Cattaneo F; Ramelli F; Mazzucchelli L; Frattini M
    Cytopathology; 2015 Oct; 26(5):288-96. PubMed ID: 25487739
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Krishnamoorthy GP; Davidson NR; Leach SD; Zhao Z; Lowe SW; Lee G; Landa I; Nagarajah J; Saqcena M; Singh K; Wendel HG; Dogan S; Tamarapu PP; Blenis J; Ghossein RA; Knauf JA; Rätsch G; Fagin JA
    Cancer Discov; 2019 Feb; 9(2):264-281. PubMed ID: 30305285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A thyroid EIF1AX story: how clinical, cytologic, and molecular surveillance led to appropriate management.
    Geisler DL; Karslioglu French E; Yip L; Nikiforova MN; Nikiforov YE; Schoedel KE; Seethala RR; Ohori NP
    J Am Soc Cytopathol; 2023; 12(2):105-111. PubMed ID: 36504010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytological features and nuclear scores: Diagnostic tools in preoperative fine needle aspiration of indeterminate thyroid nodules with RAS or BRAF K601E mutations?
    Ravella L; Lopez J; Descotes F; Giai J; Lapras V; Denier ML; Borson-Chazot F; Lifante JC; Decaussin-Petrucci M
    Cytopathology; 2021 Jan; 32(1):37-44. PubMed ID: 32803788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel nonsense EIF1AX mutation identified in a thyroid nodule histologically diagnosed as oncocytic carcinoma.
    Sponziello M; Silvestri G; Verrienti A; Perna A; Rosignolo F; Brunelli C; Pecce V; Rossi ED; Lombardi CP; Durante C; Filetti S; Fadda G
    Endocrine; 2018 Nov; 62(2):492-495. PubMed ID: 29700698
    [No Abstract]   [Full Text] [Related]  

  • 17. Patient with multiple genetically distinct thyroid nodules including papillary thyroid carcinoma harboring novel YWHAG-BRAF fusion.
    Lin R; Wang ZX; Cottrill E; Badjatia N; Gargano SM
    Cancer Genet; 2022 Aug; 266-267():51-56. PubMed ID: 35780657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
    Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
    Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis.
    Borrelli N; Ugolini C; Giannini R; Antonelli A; Giordano M; Sensi E; Torregrossa L; Fallahi P; Miccoli P; Basolo F
    Cancer Cytopathol; 2016 May; 124(5):340-9. PubMed ID: 26749005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of somatic TERT promoter mutations in familial nonmedullary thyroid carcinomas.
    Marques IJ; Moura MM; Cabrera R; Pinto AE; Simões-Pereira J; Santos C; Menezes FD; Montezuma D; Henrique R; Rodrigues Teixeira M; Leite V; Cavaco BM
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):394-399. PubMed ID: 28502101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.